New therapeutic strategy with extracorporeal membrane oxygenation for refractory hepatopulmonary syndrome after liver transplant: A case report

Table 1 Review of extracorporeal membrane oxygenation in hepatopulmonary syndrome

Ref.	Age	Gender	MELD score	Etiology of liver disease	Pre-LT PaO2 (mmHg)	ECMO initiation	ECMO duration	ICU stay (d)	Days to discharge	State
Monsel et al[12]	51	M	N/D	OH	51	- 5	5	36	48	Alive
Auzinger et al[10]	44	N/D	N/D	OH	35	13	21	27	N/D	Alive
Sharma et al[5]	60	F	22	NASH	50	11	13	N/D	N/D	Alive
Braun et al[9]	50	M	25	OH	No	12	49	61	61	Dead
Braun et al[9]	28	M	31	Non-cirrhotic PH	No	5	10	58	58	Dead
Goussous et al[8]	52	F	26	HCV	No	1	10	N/D	N/D	Alive
Herden et al[7]	62	F	12	Idiopathic	No	7	6	N/D	N/D	Alive
Hogen et al[11]	42	F	N/D	N/D	52	Intraoperative	12	N/D	N/D	Alive
Laici et al[3]	45	F	31	OH	50	Intraoperative	36 h	N/D	42	Alive
This report	59	M	12	OH	57	3	9	N/D	28	Alive

M: Male; F: Female; MELD: Model for End-Stage Liver Disease; OH: Enolic; PH: Portal hypertension; N/D: Not described; LT: Liver transplant; PaO₂: Arterial partial pressure of oxygen; ECMO: Extracorporeal membrane oxygenation; ICU: Intensive care unit; NASH: Nonalcoholic steatohepatitis; HCV: Hepatitis C virus.